Prevalence of occult HCV infection in hemodialysis and kidney-transplanted patients: A systematic review

Dolatimehr, Fardin; Khosravi, Mohammad Hossein; Rezaee-Zavareh, Mohammad Saeid; Alavian, Seyed Moayed

doi:10.2217/fvl-2016-0138

Download

Article (Scientific journals)

Prevalence of occult HCV infection in hemodialysis and kidney-transplanted patients: A systematic review

Dolatimehr, Fardin; Khosravi, Mohammad Hossein; Rezaee-Zavareh, Mohammad Saeid et al.

2017 • In Future Virology, 12 (5), p. 315 - 322

Peer Reviewed verified by ORBi

Permalink
https://hdl.handle.net/2268/291093

DOI
10.2217/fvl-2016-0138

Files (1)Send to Details Statistics Bibliography Similar publications

Files

Full Text

dolatimehr2017.pdf

Author postprint (1.74 MB)

Download

All documents in ORBi are protected by a user license.

Send to

RIS BibTex APA Chicago Permalink X Linkedin

Details

Keywords :

kidney transplantation; occult hepatitis C; renal dialysis; Virology

Abstract :

[en] Aim: We performed a systematic review for determining the prevalence rate of occult HCV infection (OCI) among hemodialysis and kidney-transplanted (KT) patients. Methods: Electronic databases were searched with appropriate search strategies. We considered positive result for tests of HCV-RNA in peripheral blood mononuclear cell, ultracentrifuged serum or hepatocytes in the absence of HCV-RNA and anti-HCV antibody in patients' sera as the definition of OCI. Results: Two studies reported OCI prevalence rate of 0 and 2% among KT patients. Results of OCI prevalence rates among hemodialysis patients varied between 0 and 45% in ten different included studies showing a great heterogeneity. Conclusion: Although we still need more evidence to support our results, they suggest that checking OCI in hemodialysis or KT patients with unexplained signs of liver diseases may have some benefit.

Disciplines :

Gastroenterology & hepatology

Author, co-author :

Dolatimehr, Fardin; Stud. Research Commitee, Baqiyatallah University of Medical Sciences, Tehran, Iran ; Baqiyatallah Research Center for Gastroenterology and Liver Diseases (BRCGL), Baqiyatallah University of Medical Sciences, Tehran, Iran ; Middle East Liver Diseases (MELD) Center, Tehran, Iran

Khosravi, Mohammad Hossein ; Université de Liège - ULiège > Faculté de Médecine > Doct. sc. méd. (paysage)

Rezaee-Zavareh, Mohammad Saeid; Stud. Research Commitee, Baqiyatallah University of Medical Sciences, Tehran, Iran ; Baqiyatallah Research Center for Gastroenterology and Liver Diseases (BRCGL), Baqiyatallah University of Medical Sciences, Tehran, Iran ; Middle East Liver Diseases (MELD) Center, Tehran, Iran

Alavian, Seyed Moayed; Baqiyatallah Research Center for Gastroenterology and Liver Diseases (BRCGL), Baqiyatallah University of Medical Sciences, Tehran, Iran ; Middle East Liver Diseases (MELD) Center, Tehran, Iran

Language :

English

Title :

Prevalence of occult HCV infection in hemodialysis and kidney-transplanted patients: A systematic review

Publication date :

May 2017

Journal title :

Future Virology

ISSN :

1746-0794

Publisher :

Future Medicine Ltd.

Volume :

Issue :

Pages :

315 - 322

Peer reviewed :

Peer Reviewed verified by ORBi

Additional URL :

https://www.futuremedicine.com/doi/pdf/10.2217/fvl-2016-0138

Available on ORBi :

since 21 May 2022

Statistics

Number of views

32 (1 by ULiège)

Number of downloads

32 (0 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

Bibliography

Rostami Z, Nourbala MH, Alavian SM, Bieraghdar F, Jahani Y, Einollahi B. The impact of hepatitis C virus infection on kidney transplantation outcomes: a systematic review of 18 observational studies: the impact of HCV on renal transplantation. Hepat. Mon. 11(4), 247-254 (2011).
Alavian SM, Kabir A, Ahmadi AB, Lankarani KB, Shahbabaie MA, Ahmadzad-Asl M. Hepatitis C infection in hemodialysis patients in Iran: a systematic review. Hemodial. Int. 14(3), 253-262 (2010).
Castillo I, Pardo M, Bartolome J et al. Occult hepatitis C virus infection in patients in whom the etiology of persistently abnormal results of liver-function tests is unknown. J. Infect. Dis. 189(1), 7-14 (2004).
Carreno V, Castillo I, Bartolome J et al. Comparison of hepatitis C virus RNA detection in plasma, whole blood and peripheral blood mononuclear cells of patients with occult hepatitis C virus infection. J. Clin. Virol. 31(4), 312-313 (2004).
Bartolomé J, López-Alcorocho JM, Castillo I et al. Ultracentrifugation of serum samples allows detection of hepatitis C virus RNA in patients with occult hepatitis C. J. Virol. 81(14), 7710-7715 (2007).
Pardo M, Lopez-Alcorocho JM, Rodriguez-Inigo E, Castillo I, Carreno V. Comparative study between occult hepatitis C virus infection and chronic hepatitis C. J. Viral Hepat. 14(1), 36-40 (2007).
Keyvani H, Bokharaei-Salim F, Monavari SH et al. Occult hepatitis C virus infection in candidates for liver transplant with cryptogenic cirrhosis. Hepat. Mon. 13(8), e11290 (2013).
Castillo I, Bartolome J, Quiroga JA, Carreno V. High prevalence of occult hepatitis C virus infection in patients with chronic hepatitis B virus infection. J. Med. Microbiol. 62(Pt 8), 1235-1238 (2013).
Rezaee Zavareh MS, Alavian SM, Karimisari H, Shafiei M, Saiedi Hosseini SY. Occult hepatitis C virus infection in patients with autoimmune hepatitis. Hepat. Mon. 14(8), e16089 (2014).
Parodi C, Culasso A, Aloisi N et al. Evidence of occult HCV genotypes in haemophilic individuals with unapparent HCV mixed infections. Haemophilia 14(4), 816-822 (2008).
Fabrizi F, Martin P. Occult hepatitis C virus infection in hemodialysis. J. Am. Soc. Nephrol. 19(12), 2248-2250 (2008).
Baid-Agrawal S, Schindler R, Reinke P et al. Prevalence of occult hepatitis C infection in chronic hemodialysis and kidney transplant patients. J. Hepatol. 60(5), 928-933 (2014).
Rezaee-Zavareh MS, Hadi R, Karimi-Sari H et al. Occult HCV infection: the current state of knowledge. Iran. Red Crescent Med. J. 17(11), e34181 (2015).
Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann. Intern. Med. 151(4), 264-269, w264 (2009).
Daglar D, Ergani A, Demirbakan H et al. Investigation of hepatitis B and hepatitis C virus infections by serological and molecular methods in hemodialysis patients. Mikrobiyol. Bul. 48(1), 143-150 (2014).
Voiculescu M, Iliescu L, Ionescu C et al. A cross-sectional epidemiological study of HBV, HCV, HDV and HEV prevalence in the subCarpathian and south-eastern regions of Romania. J. Gastrointestin. Liver Dis. 19(1), 43-48 (2010).
Mederacke I, Meier M, Luth JB et al. Different kinetics of HBV and HCV during haemodialysis and absence of seronegative viral hepatitis in patients with end-stage renal disease. Nephrol. Dial. Transplant. 26(8), U2648-U1901 (2011).
Yakaryilmaz F, Gurbuz OA, Guliter S et al. Prevalence of occult hepatitis B and hepatitis C virus infections in Turkish hemodialysis patients. Ren. Fail. 28(8), 729-735 (2006).
Hooda AK, Varma PP, Chopra GS, Kaur J. High prevalence of hepatitis C virusribonucleic acid positivity in anti-hepatitis C virus negative renal transplant patients. Med. J. Armed Forces India 68(2), 123-128 (2012).
Rinonce HT, Yano Y, Utsumi T et al. Hepatitis B and C virus infection among hemodialysis patients in Yogyakarta, Indonesia: prevalence and molecular evidence for nosocomial transmission. J. Med. Virol. 85(8), 1348-1361 (2013).
Li H, Wang SX. Hepatitis C viral infection in a Chinese hemodialysis unit. Chin. Med. J. (Engl.) 123(24), 3574-3577 (2010).
Thongsawat S, Maneekarn N, Kuniholm MH et al. Occult hepatitis C virus infection during an outbreak in a hemodialysis unit in Thailand. J. Med. Virol. 80(5), 808-815 (2008).
Oesterreicher C, Hammer J, Koch U et al. HBV and HCV genome in peripheral-blood mononuclear-cells in patients undergoing chronic-hemodialysis. Kidney Int. 48(6), 1967-1971 (1995).
Barril G, Castillo I, Arenas MD et al. Occult hepatitis C virus infection among hemodialysis patients. J. Am. Soc. Nephrol. 19(12), 2288-2292 (2008).
Choi YS, Lee JE, Nam SJ et al. Two distinct functional patterns of hepatitis C virus (HCV)-specific T cell responses in seronegative, aviremic patients. PLoS ONE 8(4), e62319 (2013).
Barril G, Quiroga JA, Arenas MD et al. Impact of isolated hepatitis C virus (HCV) core-specific antibody detection and viral RNA amplification among HCVseronegative dialysis patients at risk for infection. J. Clin. Microbiol. 52(8), 3053-3056 (2014).
Bozkurt I, Aygen B, Gokahmetoglu S, Yildiz O. Hepatitis C and occult hepatitis C infection among hemodialysis patients from central Anatolia. J. Pure Appl. Microbiol. 8(1), 435-440 (2014).
El-Shishtawy S, Sherif N, Abdallh E et al. Occult hepatitis C virus infection in hemodialysis patients; single center study. Electron. Phys. 7(8), 1619-1625 (2015).
Eslamifar A, Ramezani A, Ehteram H et al. Occult hepatitis C virus infection in Iranian hemodialysis patients. J. Nephropathol. 4(4), 116-120 (2015).
Abdelrahim SS, Khiry RM, Esmail MA, Ragab M, Abdel-Hamid M, Abdelwahab SF. Occult hepatitis C virus infection among Egyptian hemodialysis patients. J. Med. Virol. 88(8), 1388-1393 (2016).
Rahnavardi M, Hosseini Moghaddam SM, Alavian SM. Hepatitis C in hemodialysis patients: current global magnitude, natural history, diagnostic difficulties, and preventive measures. Am. J. Nephrol. 28(4), 628-640 (2008).
Nicot F, Kamar N, Mariame B, Rostaing L, Pasquier C, Izopet J. No evidence of occult hepatitis C virus (HCV) infection in serum of HCV antibody-positive HCV RNA-negative kidney-transplant patients. Transpl. Int. 23(6), 594-601 (2010).
Rezaee-Zavareh MS, Ramezani-Binabaj M, Einollahi B. Occult hepatitis C virus infection in dialysis patients: does it need special attention? Saudi J. Kidney Dis. Transpl. 26(2), 368-369 (2015).
Rezaee-Zavareh MS, Ramezani-Binabaj M, Moayed Alavian S. Screening for occult hepatitis C virus infection: does it need special attention? Hepatology 62(1), 321-322 (2015).
Alavian SM, Hajarizadeh B, Bagheri Lankarani K et al. Recommendations for the clinical management of hepatitis C in Iran: a consensus-based national guideline. Hepat. Mon. 16(8), e40959 (2016).
Alavian SM, Rezaee-Zavareh MS. The Middle East and hepatitis C virus infection: does it need special attention? Lancet Infect. Dis. 16(9), 1006-1007 (2016).
Alavian SM, Bagheri-Lankarani K, Mahdavi-Mazdeh M, Nourozi S. Hepatitis B and C in dialysis units in Iran: changing the epidemiology. Hemodial. Int. 12(3), 378-382 (2008).
Alavian SM, Moghaddam SMM, Rahnavardi M. Hepatitis C among hemodialysis patients: a review on epidemiologic, diagnostic, and therapeutic Features. Hepat. Mon. 7(3), 153-162 (2007).
Fabrizi F, Takkouche B, Lunghi G, Dixit V, Messa P, Martin P. The impact of hepatitis C virus infection on survival in dialysis patients: meta-analysis of observational studies. J. Viral Hepat. 14(10), 697-703 (2007).
Rezaee-Zavareh MS, Einollahi B. Treatment of occult hepatitis C virus infection: does it need special attention? Hepat. Mon. 14(7), e16665 (2014).
Hesamizadeh K, Sharafi H, Rezaee-Zavareh MS, Behnava B, Alavian SM. Next steps toward eradication of hepatitis C in the era of direct acting antivirals. Hepat. Mon. 16(4), e37089 (2016).
Rezaee Zavareh MS, Alavian SM. Occult hepatitis C infection should be more noticed with new treatment strategies. Hepat. Mon. 15(11), e33462 (2015).
Elmasry S, Wadhwa S, Bang BR et al. Detection of occult hepatitis C virus infection in patients who achieved a sustained virologic response to direct-acting antiviral agents for recurrent infection after liver transplantation. Gastroenterology 152(3), 550.e8-553.e8 (2016).